News

European stocks near two-week low on trade worries, Michelin slump

European stocks dipped on Tuesday on renewed worries about a U.S.-China trade war and as Michelin’s shares slid to a more than two-year low after the French tyre maker cut its annual forecast. The pan-European STOXX 600 index was down 0.6% as of 0718 GMT, hitting a near two-week low following a short-livedbounce on Monday. Global stocks sold off sharply on Friday after U.S. President Donald

POL brings Razgir-1 well onstream

Pakistan Oilfields Limited (POL) announced on Tuesday that the Razgir-1 well was brought onstream on October 12 at the Tolanj Production Facility after securing approvals from the regulatory authorities. The company shared the development in a notice to the Pakistan Stock Exchange (PSX). “Production from the well is being gradually ramped up and is expected to reach the flow rate of 25.1 mil

Intra-day update: rupee registers improvement against US dollar

The Pakistani rupee posted a marginal gain against the US dollar, appreciating 0.04% during the opening hours of trading in the inter-bank market on Tuesday. At 10:30am, the local currency was hovering at 281.05, up by Re0.11 against the US dollar. On Monday, the local unit closed at 281.16. Internationally, the US dollar held steady on Tuesday as US President Donald Trump’s watered-down

Pakistan’s Beco Steel to diversify into steel rebar production, plans 5MW solar plant

Beco Steel Limited (BECO) has announced plans to diversify its operations into the production of deformed steel bars, marking a major step in its long-term expansion and growth strategy. The listed company disclosed the development in its notice to the bourse. The steel-maker said it currently operates in both ferrous and non-ferrous segments, catering to both local and export markets. It added

Using IPO proceeds, Pakistan’s BF Biosciences launches Zeptide to expand diabetes portfolio

In a major boost to Pakistan’s pharmaceutical sector, BF Biosciences Limited has introduced Zeptide (Tirzepatide), an advanced dual-action therapy for Type 2 diabetes and obesity, developed and manufactured at its local facility. The pharma shared the development in its notice to the Pakistan Stock Exchange (PSX) on Tuesday. Tirzepatide, approved by the US Food and Drug Administration (FDA),